Point72 Asset Management
AAPG

Point72 Asset Management’s Ascentage Pharma AAPG Stock Holding History

Point72 Asset Management’s Portfolio AAPG Stock Details AAPG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$383K Sell
16,056
-670
-4% -$16.5K ﹤0.01% 3253
2025
Q4 		$439K Buy
+16,726
New +$548K ﹤0.01% 3300

Other funds holding AAPG

XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Point72 Asset Management's AAPG Position: Q1 2026 in Review

Point72 Asset Management reduced its Ascentage Pharma (AAPG) stake by 4% in Q1 2026, selling an estimated $16.5K and leaving 16,056 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #3253.

Point72 Asset Management first reported a position in AAPG in Q4 2025 and has held it in 2 quarters since. The position peaked at $439K in Q4 2025. 7 funds tracked by Wall St. Rank hold AAPG as of Q1 2026.

  • Point72 Asset Management held 16,056 shares of Ascentage Pharma worth $383K as of Q1 2026.
  • Point72 Asset Management sold 670 Ascentage Pharma shares in Q1 2026, an estimated $16.5K.
  • Ascentage Pharma made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3253 holding.
  • Point72 Asset Management first reported a position in Ascentage Pharma in Q4 2025 and has held it in 2 quarters since.
  • Point72 Asset Management's Ascentage Pharma position peaked at $439K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Ascentage Pharma as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.